Tiemann Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.05M Buy
2,234
+435
+24% +$441K 0.81% 26
2025
Q4
$1.93M Sell
1,799
-8
-0.4% -$7.65K 0.75% 29
2025
Q3
$1.38M Sell
1,807
-35
-2% -$26K 0.53% 41
2025
Q2
$1.44M Hold
1,842
0.59% 38
2025
Q1
$1.52M Buy
1,842
+5
+0.3% +$4.16K 0.69% 31
2024
Q4
$1.42M Sell
1,837
-30
-2% -$24.8K 0.63% 37
2024
Q3
$1.65M Sell
1,867
-113
-6% -$102K 0.71% 33
2024
Q2
$1.79M Sell
1,980
-27
-1% -$21.6K 0.8% 29
2024
Q1
$1.56M Buy
2,007
+25
+1% +$17.8K 0.7% 34
2023
Q4
$1.16M Sell
1,982
-19
-0.9% -$11.1K 0.56% 41
2023
Q3
$1.07M Sell
2,001
-1
-0% -$515 0.57% 41
2023
Q2
$939K Buy
2,002
+10
+0.5% +$4.19K 0.48% 53
2023
Q1
$684K Buy
1,992
+85
+4% +$28.7K 0.37% 63
2022
Q4
$698K Buy
1,907
+125
+7% +$44.3K 0.41% 62
2022
Q3
$576K Sell
1,782
-45
-2% -$14.3K 0.37% 59
2022
Q2
$592K Buy
1,827
+82
+5% +$24.6K 0.32% 71
2022
Q1
$500K Buy
1,745
+35
+2% +$9.01K 0.23% 93
2021
Q4
$472K Sell
1,710
-50
-3% -$12.7K 0.2% 114
2021
Q3
$407K Sell
1,760
-50
-3% -$12.3K 0.19% 119
2021
Q2
$415K Sell
1,810
-10
-0.5% -$2.01K 0.19% 125
2021
Q1
$340K Sell
1,820
-83
-4% -$16.2K 0.17% 140
2020
Q4
$321K Hold
1,903
0.17% 136
2020
Q3
$282K Sell
1,903
-25
-1% -$3.87K 0.17% 138
2020
Q2
$317K Buy
1,928
+329
+21% +$50.5K 0.22% 119
2020
Q1
$222K Hold
1,599
0.19% 137
2019
Q4
$210K Sell
1,599
-275
-15% -$31.9K 0.14% 176
2019
Q3
$210K Sell
1,874
-275
-13% -$30.6K 0.15% 170
2019
Q2
$238K Hold
2,149
0.17% 157
2019
Q1
$279K Hold
2,149
0.21% 129
2018
Q4
$249K Hold
2,149
0.22% 135
2018
Q3
$231K Buy
+2,149
New +$215K 0.18% 158
2017
Q2
Sell
-2,599
Closed -$219K 164
2017
Q1
$219K Hold
2,599
0.2% 149
2016
Q4
$191K Hold
2,599
0.19% 154
2016
Q3
$209K Hold
2,599
0.19% 157
2016
Q2
$205K Buy
+2,599
New +$196K 0.19% 155
2016
Q1
Sell
-2,824
Closed -$238K 154
2015
Q4
$238K Sell
2,824
-1,000
-26% -$83K 0.24% 133
2015
Q3
$320K Buy
3,824
+200
+6% +$16.9K 0.35% 92
2015
Q2
$303K Sell
3,624
-75
-2% -$5.71K 0.31% 106
2015
Q1
$269K Buy
3,699
+25
+0.7% +$1.78K 0.28% 118
2014
Q4
$253K Buy
3,674
+50
+1% +$3.38K 0.27% 121
2014
Q3
$235K Hold
3,624
0.26% 124
2014
Q2
$225K Buy
3,624
+75
+2% +$4.47K 0.25% 127
2014
Q1
$209K Buy
+3,549
New +$198K 0.23% 139

Other funds holding LLY

Tiemann Investment Advisors's LLY Position: Q1 2026 in Review

Tiemann Investment Advisors increased its Eli Lilly (LLY) stake by 24% in Q1 2026, buying an estimated $441K and bringing the position to 2,234 shares worth $2.05M. The position accounts for 0.81% of the portfolio, ranked #26.

Tiemann Investment Advisors first reported a position in LLY in Q1 2014 and has held it in 43 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Tiemann Investment Advisors held 2,234 shares of Eli Lilly worth $2.05M as of Q1 2026.
  • Tiemann Investment Advisors bought 435 Eli Lilly shares in Q1 2026, an estimated $441K.
  • Eli Lilly made up 0.81% of Tiemann Investment Advisors's portfolio in Q1 2026, its #26 holding.
  • Tiemann Investment Advisors first reported a position in Eli Lilly in Q1 2014 and has held it in 43 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Tiemann Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.